🇺🇸 20-valent pneumococcal conjugate vaccine (20vPnC) in United States

20-valent pneumococcal conjugate vaccine (20vPnC) (20-valent-pneumococcal-conjugate-vaccine-20vpnc) regulatory status in United States.

Marketing authorisation

FDA

  • Status: approved

20-valent pneumococcal conjugate vaccine (20vPnC) in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Other Infectious Disease approved in United States

Frequently asked questions

Is 20-valent pneumococcal conjugate vaccine (20vPnC) approved in United States?

Yes. FDA has authorised it.

Who is the marketing authorisation holder for 20-valent pneumococcal conjugate vaccine (20vPnC) in United States?

Pfizer Inc. is the originator. The local marketing authorisation holder may differ — check the official source linked above.